Difficulty: Medium
Average Score: 88%
Practice
The nurse is reviewing the drug-approval process in the United States and learns that the Food and Drug Administration Modernization Act of 1997 contains which provisions? (Select all that apply.)
Correct answer
A
Rationale
The correct answer is A: Review of new drugs is accelerated. The FDA Modernization Act of 1997 aimed to expedite the drug-approval process by streamlining regulations and providing more efficient pathways for approval. This provision allowed for faster review of new drugs to get them to market more quickly.
Choice B is incorrect because off-label use of drugs is not specifically addressed in the FDA Modernization Act of 1997. Choice C is incorrect because the privacy of individually identifiable health information is more related to HIPAA regulations rather than the FDA Modernization Act. Choice D is incorrect because the act does not require drug companies to offer advanced notice of plans to discontinue drugs.
Choice B is incorrect because off-label use of drugs is not specifically addressed in the FDA Modernization Act of 1997. Choice C is incorrect because the privacy of individually identifiable health information is more related to HIPAA regulations rather than the FDA Modernization Act. Choice D is incorrect because the act does not require drug companies to offer advanced notice of plans to discontinue drugs.